Study Reference No. 22-1058

Study Type Demographic Gender Age Location Compensation
Investigational Oral Medicated Study Healthy volunteers Males and Females 18 - 55 years old Saint Petersburg FL $1,375.00
Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)] capsule is bioequivalent (where the active test study drug is absorbed into the body at the same rate and amount as an already approved drug) to a currently marketed capsule, as well as to monitor the safety of the study participants.

Study Schedule

General Screening


Medical Screening

Thu, Apr 07, Tue, Apr 12 and Wed, Apr 13

Study Visit(s)

Group 1 / Period I
Check-in: Fri, Mar 04,2022
Check-out: Sun, Mar 06,2022
Ambulatory Visit 1: Sun, Mar 06,2022
Ambulatory Visit 2: Mon, Mar 07,2022

Group 1 / Period II
Check-in: Sun, Mar 13,2022
Check-out:Tue, Mar 15,2022
Ambulatory Visit 1: Tue, Mar 15,2022
Ambulatory Visit 2: Wed, Mar 16,2022

Group 2 / Period I - TBD

Group 2 / Period II - TBD

Follow-Up Visit(s)


Other Notes

General good health and non-smoker

Study requires overnight stays